Skip to main content

S&P 500 —

Nasdaq-100 —

Dow —

Nasdaq · Common stock

Definium Therapeutics (DFTX)

$35.68 +$0.01 (+0.03%)

Day’s range
$34.74–$36.35
Volume
1.1M

DFTX price history

DFTX closed at $35.68 on Oct. 26, 2026. Over the past year, its daily close ranged from $15.05 on Jan. 16, 2026 to $48.45 on July 9, 2026.

Source: third-party providers. Daily closing prices, adjusted for stock splits; dividends not included. The price scale runs from $10 to $50, not from zero.
Data table: DFTX daily closes, the past year
DFTX daily closing prices, Jan. 15, 2026 to Oct. 26, 2026, newest first
DateClose
Oct. 26, 2026$35.68
Oct. 23, 2026$35.67
Oct. 22, 2026$36.00
Oct. 21, 2026$35.49
Oct. 20, 2026$35.09
Oct. 19, 2026$32.97
Oct. 16, 2026$32.10
Oct. 15, 2026$34.26
Oct. 14, 2026$34.24
Oct. 13, 2026$34.38
Oct. 12, 2026$35.20
Oct. 9, 2026$36.90
Oct. 8, 2026$34.18
Oct. 7, 2026$35.09
Oct. 6, 2026$35.62
Oct. 5, 2026$36.23
Oct. 2, 2026$37.40
Oct. 1, 2026$37.60
Sept. 30, 2026$38.06
Sept. 29, 2026$38.21
Sept. 28, 2026$38.41
Sept. 25, 2026$36.17
Sept. 24, 2026$36.73
Sept. 23, 2026$37.65
Sept. 22, 2026$40.32
Sept. 21, 2026$39.28
Sept. 18, 2026$38.81
Sept. 17, 2026$38.68
Sept. 16, 2026$37.85
Sept. 15, 2026$36.82
Sept. 14, 2026$40.25
Sept. 11, 2026$38.89
Sept. 10, 2026$37.73
Sept. 9, 2026$37.99
Sept. 8, 2026$38.23
Sept. 4, 2026$38.09
Sept. 3, 2026$38.00
Sept. 2, 2026$38.90
Sept. 1, 2026$38.50
Aug. 31, 2026$39.72
Aug. 28, 2026$40.98
Aug. 27, 2026$43.82
Aug. 26, 2026$43.77
Aug. 25, 2026$44.81
Aug. 24, 2026$43.27
Aug. 21, 2026$44.91
Aug. 20, 2026$45.40
Aug. 19, 2026$45.82
Aug. 18, 2026$46.18
Aug. 17, 2026$45.26
Aug. 14, 2026$42.63
Aug. 13, 2026$43.90
Aug. 12, 2026$42.79
Aug. 11, 2026$40.91
Aug. 10, 2026$45.15
Aug. 7, 2026$46.14
Aug. 6, 2026$46.14
Aug. 5, 2026$44.39
Aug. 4, 2026$42.32
Aug. 3, 2026$41.79
July 31, 2026$43.52
July 30, 2026$44.49
July 29, 2026$42.16
July 28, 2026$41.96
July 27, 2026$42.65
July 24, 2026$43.17
July 23, 2026$42.93
July 22, 2026$43.67
July 21, 2026$45.08
July 20, 2026$42.80
July 17, 2026$44.29
July 16, 2026$44.10
July 15, 2026$45.66
July 14, 2026$45.98
July 13, 2026$43.65
July 10, 2026$47.07
July 9, 2026$48.45
July 8, 2026$45.32
July 7, 2026$44.48
July 6, 2026$44.33
July 2, 2026$44.19
July 1, 2026$43.40
June 30, 2026$47.04
June 29, 2026$46.55
June 26, 2026$44.95
June 25, 2026$44.79
June 24, 2026$42.13
June 23, 2026$36.18
June 22, 2026$36.67
June 18, 2026$24.48
June 17, 2026$24.43
June 16, 2026$24.16
June 15, 2026$23.77
June 12, 2026$24.75
June 11, 2026$24.11
June 10, 2026$23.24
June 9, 2026$22.95
June 8, 2026$23.02
June 5, 2026$23.55
June 4, 2026$24.59
June 3, 2026$23.59
June 2, 2026$22.86
June 1, 2026$24.06
May 29, 2026$24.19
May 28, 2026$23.48
May 27, 2026$23.52
May 26, 2026$22.88
May 22, 2026$22.50
May 21, 2026$22.65
May 20, 2026$20.87
May 19, 2026$20.02
May 18, 2026$20.48
May 15, 2026$20.99
May 14, 2026$21.35
May 13, 2026$22.01
May 12, 2026$21.16
May 11, 2026$21.40
May 8, 2026$22.05
May 7, 2026$23.20
May 6, 2026$23.42
May 5, 2026$22.40
May 4, 2026$21.75
May 1, 2026$21.70
April 30, 2026$21.88
April 29, 2026$20.49
April 28, 2026$21.27
April 27, 2026$20.98
April 24, 2026$22.48
April 23, 2026$23.26
April 22, 2026$23.08
April 21, 2026$23.84
April 20, 2026$23.18
April 17, 2026$22.68
April 16, 2026$22.46
April 15, 2026$22.15
April 14, 2026$21.93
April 13, 2026$22.25
April 10, 2026$21.53
April 9, 2026$21.42
April 8, 2026$21.02
April 7, 2026$20.58
April 6, 2026$20.43
April 2, 2026$20.68
April 1, 2026$20.60
March 31, 2026$18.90
March 30, 2026$17.50
March 27, 2026$17.88
March 26, 2026$18.94
March 25, 2026$18.47
March 24, 2026$17.79
March 23, 2026$18.10
March 20, 2026$18.40
March 19, 2026$18.66
March 18, 2026$17.64
March 17, 2026$18.09
March 16, 2026$18.32
March 13, 2026$18.06
March 12, 2026$17.98
March 11, 2026$18.63
March 10, 2026$19.05
March 9, 2026$18.35
March 6, 2026$17.66
March 5, 2026$17.55
March 4, 2026$17.76
March 3, 2026$17.69
March 2, 2026$17.18
Feb. 27, 2026$17.45
Feb. 26, 2026$17.29
Feb. 25, 2026$17.62
Feb. 24, 2026$17.45
Feb. 23, 2026$16.95
Feb. 20, 2026$17.13
Feb. 19, 2026$17.27
Feb. 18, 2026$17.38
Feb. 17, 2026$16.90
Feb. 13, 2026$15.75
Feb. 12, 2026$16.23
Feb. 11, 2026$17.35
Feb. 10, 2026$17.37
Feb. 9, 2026$17.35
Feb. 6, 2026$16.90
Feb. 5, 2026$16.25
Feb. 4, 2026$17.03
Feb. 3, 2026$17.90
Feb. 2, 2026$18.23
Jan. 30, 2026$16.88
Jan. 29, 2026$17.24
Jan. 28, 2026$16.84
Jan. 27, 2026$17.48
Jan. 26, 2026$16.51
Jan. 23, 2026$17.40
Jan. 22, 2026$16.97
Jan. 21, 2026$17.15
Jan. 20, 2026$16.78
Jan. 16, 2026$15.05
Jan. 15, 2026$15.38

Key figures

52-week range
—
Average daily volume
2.2MPast 3 months
Market value
$4.79B
Dividend yield
—
From 52-week high
—

Price change

1 month
−1.35%
3 months
−17.35%
Year to date
—
1 year
—

What Wall Street says about DFTX

In the past 90 days, Wall Street firms published 15 rating or price-target actions on DFTX: 2 new ratings, 3 reiterated ratings and 10 raised price targets.

Rating and price-target actions on DFTX, past 90 days
ActionRating
JP MorganInitiates coverageOverweight$84
BairdRaises targetOutperform$75 to $79
Canaccord GenuityRaises targetBuy$64 to $78
HC Wainwright & Co.ReiteratesBuy$70
NeedhamReiteratesBuy$66
RBC CapitalReiteratesOutperform$66
B of A SecuritiesInitiates coverageBuy$75
Maxim GroupRaises targetBuy$50 to $55
BairdRaises targetOutperform$57 to $75
Canaccord GenuityRaises targetBuy$58 to $64
Jones TradingRaises targetBuy$74 to $90
RBC CapitalRaises targetOutperform$57 to $66
Wells FargoRaises targetOverweight$68 to $72
NeedhamRaises targetBuy$50 to $66
Piper SandlerRaises targetOverweight$73 to $75

Ratings and price targets are the firms’ own opinions, reported as published.

Not investment advice.

About Definium Therapeutics, Inc. Common Shares

Definium Therapeutics Inc is developing inventive, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction. Its late-stage pipeline includes four Phase 3 trials-two each for GAD and MDD-anchored by its candidate, DT120 ODT, which has received FDA Breakthrough Therapy Designation for GAD. In parallel, the Company is advancing its commercial and operational readiness to support a care model and prepare for the potential launch of DT120 ODT, if approved and marketed. The company operates in one reportable segment relating to the research and development of the company's neurological drug development platform.

Headquarters
New York, N.Y.
Employees
106
Listed
March 3, 2020
Sector
Materials
Industry
Medicinal chemicals & botanical products

definiumtx.com, the company’s website

In WallStreetDigest editions

No WallStreetDigest article about DFTX is on the site yet.

  • TRLVTrulieve Cannabis Corp.
  • CRONCronos Group Inc. Common Share
  • TLRYTilray Brands, Inc. Common Stock
  • CGCCanopy Growth Corporation Common Shares
  • USNAUSANA Health Sciences Inc
  • NAGENiagen Bioscience, Inc. Common Stock